Skip to Content

Carl Zeiss Meditec AG

AFX: XETR (DEU)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€56.00NczphxBnscwrx

Carl Zeiss Earnings: Improving Conditions Fuel Sales, but Weak Consumables Pose Margin Pressure

Narrow-moat Carl Zeiss reported third-quarter results that were ahead of our expectations, with total sales up 12.1% year over year. Improving supply conditions and ramped up production helped meet healthy demand across all regions and fueled strong top-line growth. However, operating margin so far for the year continues to lag due to poor product mix and high spending. After accounting for our updated near-term outlook, we lower our fair value estimate to EUR 87 from EUR 90.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of AFX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center